Published in Eur J Cardiothorac Surg on July 01, 2004
Therapeutic modalities for Pancoast tumors. J Thorac Dis (2014) 1.17
Diagnostic imaging in the preoperative management of lung cancer. Surg Today (2013) 0.87
Superior sulcus tumors (Pancoast tumors). Ann Transl Med (2016) 0.84
Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment. J Thorac Dis (2013) 0.83
Palliative care in patients with lung cancer. Contemp Oncol (Pozn) (2013) 0.82
Treatment of pancoast tumors from the surgeons prospective: re-appraisal of the anterior-manubrial sternal approach. J Cardiothorac Surg (2010) 0.82
Total video-assisted thoracoscopic (VATS) resection of a left-sided sulcus superior tumor after induction radiochemotherapy: video and review. Surg Endosc (2014) 0.80
A Case of Pancoast Tumor with Unusual Presentation. J Brachial Plex Peripher Nerve Inj (2015) 0.75
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Management of lung nodules detected by volume CT scanning. N Engl J Med (2009) 6.79
A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med (2003) 4.52
Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J (2005) 3.58
Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med (2013) 3.47
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol (2002) 2.86
Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am J Respir Crit Care Med (2010) 2.78
Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest (2012) 2.77
CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax (2011) 2.20
Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA (2011) 1.94
Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res (2007) 1.90
Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med (2011) 1.89
Completeness of lung cancer surgery: is mediastinal dissection common practice? Eur J Cardiothorac Surg (2012) 1.86
Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax (2011) 1.82
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis (2013) 1.69
Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail (2006) 1.68
Results of surgical treatment of T4 non-small cell lung cancer. Eur J Cardiothorac Surg (2003) 1.65
Computed tomography-quantified emphysema distribution is associated with lung function decline. Eur Respir J (2012) 1.65
Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum (2007) 1.63
Gender and physical activity one year after myocardial revascularization for stable angina. Interact Cardiovasc Thorac Surg (2007) 1.44
Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J (2013) 1.42
Effects of telemonitoring in patients with chronic obstructive pulmonary disease. Telemed J E Health (2008) 1.41
Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res (2011) 1.27
Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med (2007) 1.27
The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. Chest (2012) 1.23
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ (2006) 1.22
A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med (2007) 1.22
Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Br J Gen Pract (2006) 1.22
Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old. Fam Pract (2005) 1.15
Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures. Lung (2012) 1.14
Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. Blood (2005) 1.13
Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function. Blood (2005) 1.07
Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood (2002) 1.06
Evaluation of Quality of Life instruments for use in COPD care and research: a systematic review. Int J Nurs Stud (2012) 1.04
Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med (2005) 1.03
HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol (2002) 1.02
Comparison and clinical suitability of eight prediction models for cardiac surgery-related acute kidney injury. Nephrol Dial Transplant (2012) 1.01
Src kinases regulate PKB activation and modulate cytokine and chemoattractant-controlled neutrophil functioning. J Leukoc Biol (2002) 1.01
Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med (2002) 1.01
Expression of activated Fc gamma RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects. J Allergy Clin Immunol (2007) 0.99
Lung cancer screening CT-based prediction of cardiovascular events. JACC Cardiovasc Imaging (2013) 0.99
Comparison of on-pump or off-pump coronary artery revascularization with lung resection. Ann Thorac Surg (2007) 0.99
Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail (2007) 0.98
Primary pulmonary malignant meningioma. Ann Thorac Surg (2005) 0.96
Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest (2006) 0.95
Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res (2013) 0.95
Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol (2005) 0.94
Use of tissue expanders in adult postpneumonectomy syndrome. J Thorac Cardiovasc Surg (2007) 0.93
Role of Ca2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol-3 kinase. Eur J Biochem (2002) 0.93
Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest (2003) 0.92
Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf (2008) 0.92
IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with beta-catenin relocalization. J Leukoc Biol (2006) 0.91
Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest (2003) 0.91
Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med (2009) 0.91
Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis. Chest (2008) 0.91
Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions. BMC Fam Pract (2014) 0.91
Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis (2007) 0.91
Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf (2007) 0.90
Human suppressive neutrophils CD16bright/CD62Ldim exhibit decreased adhesion. J Leukoc Biol (2012) 0.90
Clinical utility of asthma biomarkers: from bench to bedside. Biologics (2013) 0.90
Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: psychological determinants: a cross-sectional study. Health Qual Life Outcomes (2013) 0.90
Expression of priming-associated cellular markers on neutrophils during an exacerbation of COPD. Respir Med (2006) 0.89
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. Chest (2006) 0.89
ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med (2006) 0.89
The killer immunoglobulin-like receptor (KIR) group A haplotype is associated with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant (2008) 0.89
Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 0.88
Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values? COPD (2012) 0.88
Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respir Med (2011) 0.88
Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions. Am J Respir Cell Mol Biol (2003) 0.88
Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. Eur J Cardiothorac Surg (2012) 0.87
Accuracy of symptoms, signs, and C-reactive protein for early chronic obstructive pulmonary disease. Br J Gen Pract (2012) 0.87
Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes (2010) 0.87
Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet (2010) 0.87
Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol (2008) 0.86
Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens (2007) 0.86
Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant (2010) 0.86
Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants. J Bone Miner Res (2014) 0.86
Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients. Respir Med (2006) 0.85
The impact of heart failure on the classification of COPD severity. J Card Fail (2012) 0.84
Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study. Respir Res (2013) 0.84
Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO study. Curr Med Res Opin (2008) 0.84
A Mobile Phone App to Stimulate Daily Physical Activity in Patients with Chronic Obstructive Pulmonary Disease: Development, Feasibility, and Pilot Studies. JMIR Mhealth Uhealth (2016) 0.84
Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS. J Heart Lung Transplant (2010) 0.83
Pulmonary embolism and pulmonary infarction after lung transplantation. Clin Appl Thromb Hemost (2010) 0.83
Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice? Scand J Prim Health Care (2006) 0.83
Chimerism of dendritic cell subsets in peripheral blood after lung transplantation. J Heart Lung Transplant (2011) 0.82
Visual versus automated evaluation of chest computed tomography for the presence of chronic obstructive pulmonary disease. PLoS One (2012) 0.82
Cytokine mediated suppression of TF-1 apoptosis requires PI3K activation and inhibition of Bim expression. FEBS Lett (2005) 0.82
Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2003) 0.82
Angiotensin-converting enzyme insertion/deletion polymorphism and risk and outcome of pneumonia. Chest (2007) 0.82
Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study. Eur J Clin Pharmacol (2007) 0.81
The importance of an organized follow-up for the evaluation of mortality after hospital discharge in cardiac surgery. Interact Cardiovasc Thorac Surg (2008) 0.81
Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue. Brain Behav Immun (2011) 0.81
Quantification of right-to-left shunt with (99m)Tc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia. Clin Sci (Lond) (2002) 0.80
[Spontaneous pneumothorax as the first manifestation of a hereditary condition with an increased renal cancer risk]. Ned Tijdschr Geneeskd (2009) 0.80